From: Therapeutic effects of N-acetylcysteine against malathion-induced hepatotoxicity
Measured parameters | Group 1 | Group 2 | Group 3 | Group 4 |
---|---|---|---|---|
leukocyte count (cells/mm3) | 4.1 ± 0.38 | 4.12 ± 0.47 | 11.73 ± 2.6ab | 6.81 ± 1.67abc |
MPO (U/gm) | 2.49 ± 0.38 | 2.79 ± 0.47 | 11.7 ± 5.97ab | 5.32 ± 2.37abc |
CD4 % | 32.41 ± 2.52 | 32.26 ± 4.23 | 57.18 ± 9.86ab | 44.1 ± 6.28abc |
CD8 % | 25.52 ± 2.98 | 28.16 ± 3.97 | 58.92 ± 11.69ab | 35.03 ± 8.88abc |
IL-1b | 1 ± 0.03 | 1.01 ± 0.02 | 6.80 ± 2.26ab | 2.95 ± 1abc |
IL-6 | 1.17 ± 0.6 | 1.04 ± 0.05 | 5.72 ± 1.92ab | 2.71 ± 1.0abc |
IFN-γ | 1.04 ± 0.06 | 1.04 ± 0.05 | 9.24 ± 2.82ab | 3.48 ± 1.08abc |
AChE (μ/mg protein) | 23.9 ± 3.48 | 30.08 ± 5.37a | 12.37 ± 3.69ab | 21.91 ± 5bc |